Multiple myeloma (MM) is one of the most formidable and deadly cancers known to man, with only 50% of patients surviving for more than five years after diagnosis.
8 hours ago
0
3
Psychedelic research has surged in recent years, sparking enthusiasm among clinicians, investors and the general public. Clinical trials are indicating transformative outcomes for people struggling with mental illnesses like ...
12 hours ago
0
1
The first published evidence from humans that semaglutide specifically reduces the symptoms of alcohol use disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent collaboration between ...
13 hours ago
0
3
Researchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment strategies were able to help clinical teams determine epilepsy and developmental trajectories for patients ...
16 hours ago
0
5
Health care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clinical settings has been inconsistent, in part because evaluating AI in health care remains ...
Nov 27, 2023
0
6
Regular dental checkups and oral hygiene visits are important for identifying the early stage of mouth cancer. However, the shortage of dentists in the UK has led to a rise in mouth cancers that are spotted too late, according ...
Nov 27, 2023
0
14
Results from the world's first double-blind, randomized clinical trial to find a treatment for the fungal form of a chronic disabling disease called mycetoma have demonstrated that a new oral treatment, fosravuconazole, is ...
Nov 27, 2023
0
0
Phase III trial results on a precision radiotherapy technique support a "new gold standard" for treating head and neck cancer patients. The research suggests the new approach can reduce the risk of swallowing problems after ...
Nov 24, 2023
0
56
Change in clinical practice would have clear benefits for patients undergoing major bowel surgery, according to analysis conducted by researchers from UCL and the Royal Devon and Exeter Hospital.
Nov 23, 2023
0
0
A study conducted at the University of Turku, Finland, shows that plixorafenib, a new drug developed for treating melanoma and lung cancer, may also stop the progression of cutaneous squamous cell carcinoma.
Nov 22, 2023
0
56
